| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 764752 | 1171235006 | ZEJULA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZEJULA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 comprimidos | 100 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171235006/1171235006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171235006/1171235006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 30530 | GLAXOSMITHKLINE S.A. | 2024-04-12 | 1 | 1 | 1 | 2024-04-13 | 2024-04-12 | 1 | 2024-11-14 | View Edit Delete | ||||||||||||
| 764958 | 89576 | ROSUVASTATINA/EZETIMIBA NORMON 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ROSUVASTATINA/EZETIMIBA NORMON 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89576/89576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89576/89576_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-05-17 | 1 | 1 | 1 | 2024-05-18 | 2024-05-17 | 1 | 2024-11-14 | View Edit Delete | ||||||||||||
| 764959 | 89577 | ROSUVASTATINA/EZETIMIBA NORMON 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ROSUVASTATINA/EZETIMIBA NORMON 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89577/89577_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89577/89577_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-05-17 | 1 | 1 | 1 | 2024-05-18 | 2024-05-17 | 1 | 2024-11-14 | View Edit Delete | ||||||||||||
| 764197 | 89292 | ATOMOXETINA TARBIS 100 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 100 MG CÁPSULAS DURAS EFG, 28 cápsulas | 100 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89292/89292_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89292/89292_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764199 | 89293 | ATOMOXETINA TARBIS 10 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 10 MG CÁPSULAS DURAS EFG, 28 cápsulas | 10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89293/89293_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89293/89293_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764200 | 89294 | ATOMOXETINA TARBIS 18 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 18 MG CÁPSULAS DURAS EFG, 7 cápsulas | 18 mg | 5 | 7 | 43 | 7 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89294/89294_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89294/89294_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764201 | 89294 | ATOMOXETINA TARBIS 18 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 18 MG CÁPSULAS DURAS EFG, 28 cápsulas | 18 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89294/89294_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89294/89294_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764203 | 89295 | ATOMOXETINA TARBIS 25 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 25 MG CÁPSULAS DURAS EFG, 28 cápsulas | 25 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89295/89295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89295/89295_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-06 | 1 | 1 | 1 | 2024-02-07 | 2024-02-06 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764205 | 89296 | ATOMOXETINA TARBIS 40 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 40 MG CÁPSULAS DURAS EFG, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89296/89296_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89296/89296_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-06 | 1 | 1 | 1 | 2024-02-07 | 2024-02-06 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764206 | 89297 | ATOMOXETINA TARBIS 60 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 60 MG CÁPSULAS DURAS EFG, 28 cápsulas | 60 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89297/89297_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89297/89297_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-06 | 1 | 1 | 1 | 2024-02-07 | 2024-02-06 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764207 | 89298 | ATOMOXETINA TARBIS 80 MG CÁPSULAS DURAS EFG | ATOMOXETINA TARBIS 80 MG CÁPSULAS DURAS EFG, 28 cápsulas | 80 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89298/89298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89298/89298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-06 | 1 | 1 | 1 | 2024-02-07 | 2024-02-06 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764966 | 89585 | PENTASA 4 G SUSPENSION RECTAL | PENTASA 4 G SUSPENSION RECTAL, 7 frascos de 100 ml | 4.000 mg | 6 | 7 | 14 | 7 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89585/89585_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89585/89585_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 2024-05-22 | 1 | 1 | 1 | 2024-05-23 | 2024-05-22 | 1 | 2024-11-13 | View Edit Delete | ||||||||||||
| 764626 | 89467 | DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG | DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG, 30 cápsulas | 110 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89467/89467_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89467/89467_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2024-03-27 | 1 | 1 | 1 | 2024-03-28 | 2024-03-27 | 1 | 2024-11-12 | View Edit Delete | ||||||||||||
| 764627 | 89467 | DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG | DABIGATRÁN ETEXILATO PENSA 110 MG CÁPSULAS DURAS EFG, 60 cápsulas | 110 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89467/89467_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89467/89467_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2024-03-27 | 1 | 1 | 1 | 2024-03-28 | 2024-03-27 | 1 | 2024-11-12 | View Edit Delete | ||||||||||||
| 765278 | 89670 | CELECOXIB PENSA 200 MG CAPSULAS DURAS EFG | CELECOXIB PENSA 200 MG CAPSULAS DURAS EFG, 30 cápsulas | 200 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89670/89670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89670/89670_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2024-07-03 | 1 | 1 | 1 | 2024-07-04 | 2024-07-03 | 1 | 2024-11-12 | View Edit Delete | ||||||||||||
| 698220 | 77594 | DEXKETOPROFENO PHARMA COMBIX 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | DEXKETOPROFENO PHARMA COMBIX 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 20 comprimidos (Blister PVC-PVDC-Aluminio) | 25 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77594/77594_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77594/77594_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2013-06-05 | 1 | 1 | 1 | 2013-06-05 | 2013-06-05 | 0 | 2024-11-11 | View Edit Delete | ||||||||||||
| 732162 | 86379 | POSTINOR 1,5 MG COMPRIMIDO BUCODISPERSABLE | POSTINOR 1,5 MG COMPRIMIDO BUCODISPERSABLE, 1 comprimido | 1,5 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86379/86379_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86379/86379_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2021-11-11 | 1 | 1 | 1 | 2021-11-12 | 2021-11-11 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 763230 | 1231748001 | TALVEY 2 MG/ML SOLUCION INYECTABLE | TALVEY 2 MG/ML SOLUCION INYECTABLE, 1 vial de 1,5 ml | 2 mg/ml inyectable 1,5 ml | 45 | 1 | 34 | 1 vial de 1,5 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231748001/1231748001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231748001/1231748001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 6153 | JANSSEN CILAG S.A. | 2023-08-29 | 1 | 1 | 1 | 2023-08-30 | 2023-08-29 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 763231 | 1231748002 | TALVEY 40 MG/ML SOLUCION INYECTABLE | TALVEY 40 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml | 40 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231748002/1231748002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231748002/1231748002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 6153 | JANSSEN CILAG S.A. | 2023-08-29 | 1 | 1 | 1 | 2023-08-30 | 2023-08-29 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 764119 | 1231775001 | REZZAYO 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | REZZAYO 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231775001/1231775001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231775001/1231775001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 39782 | MUNDIPHARMA PHARMACEUTICALS S.L. | 2024-01-25 | 1 | 1 | 1 | 2024-01-26 | 2024-01-25 | 1 | 2024-11-11 | View Edit Delete |
Page 104 of 1036, showing 20 records out of 20704 total, starting on record 2061, ending on 2080